AAV Production: Transfection, Prep & qPCR

Learning Goal: Designing and validating an adeno-associated virus (AAV) vector production process in suspension HEK293 cells, covering triple-transfection optimization, downstream purification via density-gradient ultracentrifugation, and qPCR-based physical titering.

  • Prerequisites: Familiarity with basic molecular biology (replication, transcription, translation), fundamental laboratory pipetting skills, and introductory genetics concepts.
  • Estimated Total Study Time: 18 Hours

Module 1: Introduction to Gene Therapy and AAV Biology

Overview

This module introduces the basic concepts of gene therapy, establishing how DNA/RNA function as therapeutic drugs. You will learn the structural and genomic biology of wild-type Adeno-Associated Virus (AAV) and how recombinant AAV (rAAV) is designed to serve as a non-pathogenic delivery vehicle.

Recommended Videos

1) Adeno Associated Virus (AAV) - An Introduction
1) Adeno Associated Virus (AAV) - An Introduction
@abmgood06:59116684
1) Adeno Associated Virus (AAV) - An Introduction

Adeno-associated virus (AAV) is a small, non-pathogenic viral vector ideal for gene therapy due to its ability to infect both dividing and quiescent cells, its low immunogenicity, and its capacity for long-term gene expression; AAV achieves this through a 4.7 kb single-stranded DNA genome that integrates into human chromosome 19 during latency and relies on helper adenovirus for productive replication, with different serotypes (such as AAV2, AAV1, AAV5, AAV8) exhibiting natural tropism toward sp

@abmgood · 06:59
  • Why this video is valuable: It provides a clear, high-level structural and genomic overview of AAV. You will learn the differences between wild-type AAV and recombinant AAV, focusing on how the rep (replication) and cap (capsid) genes are replaced with a transgene of interest to construct a safe clinical vector.
Basics of AAV Gene Therapy
Basics of AAV Gene Therapy
@ASGCT30:0180045
Basics of AAV Gene Therapy

Adeno-associated virus (AAV) is a non-pathogenic parvovirus that requires helper viruses for replication; recombinant AAV vectors are created by separating the viral genome into ITR-flanked transgenes and trans-acting rep/cap genes, enabling flexible therapeutic gene delivery with packaging capacity around 4.7 kb, where self-complementary designs enhance expression efficiency by providing immediate double-stranded templates.

@ASGCT · 30:01
  • Why this video is valuable: Presented by the American Society of Gene & Cell Therapy (ASGCT), this lecture goes deep into vector engineering. It reviews how the single-stranded DNA genome with its self-priming Inverted Terminal Repeats (ITRs) acts inside target host cells and why AAV requires a helper virus (like Adenovirus or HSV) for replication.
AAV Transfer Plasmids - Viral Vectors 101
AAV Transfer Plasmids - Viral Vectors 101
@addgene04:4739157
AAV Transfer Plasmids - Viral Vectors 101

AAV transfer plasmids contain essential elements including inverted terminal repeats (ITRs) that define the packaged region, a transgene positioned downstream of a promoter for expression, and optional regulatory elements like lox sites for controlled activation and WPRE/poly(A) sequences for enhanced expression; these components work together to ensure successful gene delivery and expression when the AAV vector is delivered to a host.

@addgene · 04:47
  • Why this video is valuable: Focuses directly on plasmid design. You will understand the crucial promoter-transgene-polyA cassette flanked by the 145-nucleotide ITRs, which are the only viral elements retained in the recombinant AAV transfer plasmid.

Knowledge Checkpoint

  • Describe the structural role and sequence significance of the 145-bp Inverted Terminal Repeats (ITRs).
  • Distinguish between wild-type AAV replication dependency and recombinant AAV (rAAV) replication incompetence.
  • Identify why the deletion of rep and cap from the transfer plasmid prevents the vector from replicating after delivery into patient tissue.

Module 2: Mammalian Cell Culture: Suspension HEK293 Cells

Overview

Biomanufacturing at scale requires transitioning from adherent cell culture monolayers to high-density suspension systems. This module focuses on maintaining, monitoring, and scaling HEK293 cells in chemically defined, serum-free suspension formats.

Recommended Videos

Mammalian Cell Culture Protocol: Counting & Passaging
Mammalian Cell Culture Protocol: Counting & Passaging
@neilcross941723:37126899
Mammalian Cell Culture Protocol: Counting & Passaging

Mammalian cell culture involves growing cells in sterile conditions within a Class II safety cabinet, using tissue culture flasks (T75 or T25) with cells attached to the plastic bottom surface under liquid growth medium; the complete medium consists of a base solution (like DMEM) supplemented with 10% fetal calf serum, and cells are passaged by washing with PBS, detaching with trypsin, counting using a hemocytometer, and replating at desired densities for experiments.

@neilcross9417 · 23:37
  • Why this video is valuable: An excellent baseline tutorial showing sterile handling, biosafety cabinet (BSC) organization, cell counting using a hemocytometer, and cell viability calculations, which are fundamental to managing any mammalian culture line.
Webinar Perfecting HEK293 Cells for Gene Therapy (INFORS HT and JIB)
Webinar Perfecting HEK293 Cells for Gene Therapy (INFORS HT and JIB)
@inforsht32240:20389
Webinar Perfecting HEK293 Cells for Gene Therapy (INFORS HT and JIB)

This webinar demonstrates how multi-cabinet incubators with independent control of temperature, CO2, agitation, relative humidity, and orbit diameter enable optimization of HEK 293 cell cultures for viral vector production in gene therapy. Research conducted by Jefferson Institute for Bioprocessing and INFORS HT showed that conditions of 110 RPM agitation, 25 mm orbit diameter, and 85% relative humidity achieved the highest cell density and specific growth rate (doubling time of approximately 12

@inforsht322 · 40:20
  • Why this video is valuable: A highly industrial webinar focused on adapting and optimizing HEK293 suspension cells for gene therapy. It covers critical parameters like shake flask agitation speeds, CO2 concentrations, and vessel orbit diameters needed to maintain viability and prevent cell clumping at high densities.
Kevin Dooley and Russell McConnell: Scaffolds for generating engineered extracellular vesicles
Kevin Dooley and Russell McConnell: Scaffolds for generating engineered extracellular vesicles
@ExtracellularVesicleClub01:21916
Kevin Dooley and Russell McConnell: Scaffolds for generating engineered extracellular vesicles

Suspension-adapted HEK293 cell lines can be grown in chemically defined medium without serum, achieving very high cell densities (10-15 million cells per ml). These cells are typically cultured at scales ranging from 200 ml to 25 liters using wave bioreactors, providing significantly more biomass compared to conventional 2D plastic culture methods.

@ExtracellularVesicleClub · 01:21
  • Why this video is valuable: This brief excerpt illustrates how suspension-adapted HEK293 lines are grown in serum-free, chemically-defined media to achieve high densities (10–15 million cells/mL), which is critical for maximizing viral vector yields per unit volume.

Gap Coverage & Self-Directed Learning

⚠️ Practical Gap Acknowledgment: While the videos cover standard cell counting and scaling strategies, they do not show a physical, step-by-step demonstration of subculturing (passaging) suspension cells in shaker flasks at the lab bench.

To fill this gap, independently search YouTube for: "HEK293 suspension cell culture protocol shaker flask" to observe hands-on flask seeding, media changes without centrifugation, and clumping mitigation techniques.

Knowledge Checkpoint

  • Calculate cell density and viability using trypan blue exclusion with a hemocytometer.
  • List the primary environmental parameters (agitation speed, orbit diameter, CO2 percentage, temperature) required for optimal HEK293 suspension culture.
  • Explain why serum-free, chemically defined media is preferred over serum-containing media for clinical AAV manufacturing.

Module 3: Upstream Bioprocessing: Triple-Transfection Optimization

Overview

This module explores upstream bioprocessing, focusing on the transient triple-transfection process. You will learn the mechanical roles of the three plasmids and transfection reagents (like Polyethylenimine or PEI) and how to optimize ratios to achieve maximum viral assembly.

Recommended Videos

AAV production in HEK293 cells
AAV production in HEK293 cells
@innovatebio25:132214
AAV production in HEK293 cells

This video demonstrates a complete protocol for producing Adeno-Associated Virus (AAV) type 2 particles in HEK293 suspension cells, covering cell culture expansion, triple transfection with three plasmids (vector, rep, and cap), cell lysis, centrifugation, and purification using chromatography with specific buffer systems (binding, wash, and elution buffers). The process requires BSL-2 containment, uses Thermo Fisher's HEK293 cells designed for suspension growth, and produces viral particles tha

@innovatebio · 25:13
  • Why this video is valuable: An outstanding, comprehensive step-by-step wet-lab tutorial showing transfection setup specifically for AAV2 production in HEK293 suspension cells. It covers cell preparation, transfection reagent formulation, and incubation.
My lecture @BHU _Wonderful experience delivering my talk at Banaras Hindu University (BHU)
My lecture @BHU _Wonderful experience delivering my talk at Banaras Hindu University (BHU)
@APNAAMERICA00:4624634
My lecture @BHU _Wonderful experience delivering my talk at Banaras Hindu University (BHU)

To produce functional AAV vectors, three plasmids are typically used together: (1) the gene of interest plasmid containing the therapeutic gene flanked by ITRs, (2) a plasmid containing the rep and cap genes necessary for viral particle formation, and (3) a helper plasmid providing additional viral functions. These three plasmids are transfected into producer cells (such as HEK 293 cells), where they are translated into proteins that assemble into viral particles.

@APNAAMERICA · 00:46
  • Why this video is valuable: This brief lecture clip breaks down the specific names and roles of the three plasmids: (1) Transgene/ITR plasmid, (2) Rep/Cap plasmid, and (3) Helper plasmid (providing Adenovirus elements E2A, E4, and VA RNA) that are co-transfected to produce functional AAV.
Mammalian Cell Transfection: Methods and Optimization \| Biology
Mammalian Cell Transfection: Methods and Optimization \| Biology
@BioResource11:0698533
Mammalian Cell Transfection: Methods and Optimization \| Biology

Transfection is the process of introducing foreign DNA into the nucleus of eukaryotic cells, resulting in transfectants; it encompasses two main types—transient transfection where DNA is expressed temporarily without genomic integration, and stable transfection where DNA becomes permanently incorporated into the host genome. The methodology involves three categories: reagent-based methods (calcium phosphate, lipofection using cationic lipids, and cationic polymers like PEI), instrument-based met

@BioResource · 11:06
  • Why this video is valuable: Focuses on the physical and chemical mechanics of transient transfection, comparing lipid-mediated transport, electroporation, and chemical precipitation. It provides invaluable optimization steps to maximize cell viability post-transfection.

Gap Coverage & Self-Directed Learning

⚠️ Practical Gap Acknowledgment: The standard video pool lacks detailed animations or visual protocols explaining how to calculate and optimize the specific stoichiometric ratios of the three plasmids (e.g., 1:1:1 or 1:1:2 ratios of Transfer:Rep/Cap:Helper) to prevent the generation of empty, non-functional viral capsids.

To fill this gap, independently search YouTube or scientific literature for: "AAV triple transfection plasmid ratio optimization PEI" to understand how to adjust plasmid molar ratios and PEI-to-DNA nitrogen-to-phosphate (N:P) ratios.

Knowledge Checkpoint

  • List the three plasmids required for transient transfection and detail the exact function of each component.
  • Describe how PEI condenses plasmid DNA into positively charged complexes to facilitate cell entry via endocytosis.
  • Explain the consequences of transfecting cells at an excessively high DNA-to-cell ratio on cell viability and the proportion of empty capsids.

Module 4: Downstream Bioprocessing: Harvest and Ultracentrifugation

Overview

Once AAV is synthesized inside host cells, the downstream challenge is harvesting the virus, lysing host cell membranes to release intracellular particles, and separating therapeutic (full) capsids from cellular debris and empty capsids. This module covers physical harvest and density-gradient ultracentrifugation.

Recommended Videos

HEK293 3D Suspension Cell Harvesting
HEK293 3D Suspension Cell Harvesting
@Thewellbio00:529777
HEK293 3D Suspension Cell Harvesting

This video demonstrates the cell harvesting process for HEK293 cells cultured in VitroGel HEK293 hydrogel. The procedure involves a simple 5-minute protocol that enables easy scaling up using flasks or bioreactors. A key feature highlighted is the enzyme-free, non-trypsin method for cell harvesting, which provides an alternative to traditional enzymatic dissociation methods. The hydrogel system supports high-quality 3D spheroid formation while maintaining xeno-free conditions (animal origin-free

@Thewellbio · 00:52
  • Why this video is valuable: Demonstrates practical harvesting of HEK293 suspension cells. This serves as a quick visual baseline for handling high-density cultures before chemical lysis.
Ultracentrifugation
Ultracentrifugation
@drbijoyachatterjee75513:0742078
Ultracentrifugation

Ultracentrifugation is a specialized centrifugation technique that spins samples at extremely high speeds (up to 150,000 rpm, generating 500,000g centrifugal force) to separate biological particles based on their sedimentation rate, which depends on particle mass, density, frictional coefficient, and centrifugal force; it is classified into preparatory centrifugation for component isolation/purification and analytical centrifugation for molecular characterization, with applications ranging from

@drbijoyachatterjee755 · 13:07
  • Why this video is valuable: This video details the intense physical mechanics behind ultracentrifugation, explaining the physics of centrifugal fields, sedimentation coefficients, and rotor selection (fixed-angle vs. swinging-bucket) required to spin down viral particles at forces up to 500,000g.
Density gradient centrifugation
Density gradient centrifugation
@quickbiochemistrybasics02:3089103
Density gradient centrifugation

Density gradient centrifugation is a separation technique where particles migrate through a liquid medium with gradually increasing density (typically sucrose solutions) during centrifugation, accumulating at positions where their own density matches the surrounding medium; this method enables purification of biological samples such as ribosome subunits, isotopically labeled DNA, and Okazaki fragments in biochemistry and molecular biology research.

@quickbiochemistrybasics · 02:30
  • Why this video is valuable: Clarifies the core difference between simple pelleting centrifugation and density-gradient separation (isopycnic centrifugation), demonstrating how biological nanoparticles migrate through gradients until they reach their matching buoyant density (equilibrium).

Gap Coverage & Self-Directed Learning

⚠️ Practical Gap Acknowledgment: Standard videos outline general density-gradient concepts (like sucrose or CsCl) but lack a practical, hands-on demonstration of pouring, loading, and fraction-recovering a discontinuous Iodixanol gradient (typically 15%, 25%, 40%, and 60% steps) which is the industry standard for AAV purification.

To fill this gap, independently search YouTube or JoVE (Journal of Visualized Experiments) for: "Iodixanol density gradient preparation AAV purification" to observe how the gradient is built from bottom to top and how fractions are recovered using needle-puncture extraction.

Knowledge Checkpoint

  • Explain how cell lysis is achieved physically (freeze-thaw cycles) vs. chemically (using detergents like Triton X-100 or Tween-20).
  • Describe why empty AAV capsids (without packaged DNA) have a lower buoyant density than full AAV capsids.
  • Calculate the centrifugal force (gg-force) when given the rotor radius (rr) and revolutions per minute (RPM).

Module 5: Analytical Validation: qPCR-Based Physical Titering

Overview

In this validation module, you will learn how to measure the concentration of packaged viral genomes (vg/mL) using Real-Time Quantitative PCR (qPCR). Crucially, you will master the preparatory enzymatic steps—specifically DNase I digestion—to eliminate contaminating plasmid DNA, ensuring you only titer functional, encapsulated genomes.

Recommended Videos

qPCR details \| quantitative real time PCR \| RT PCR \| Biotechniques
qPCR details \| quantitative real time PCR \| RT PCR \| Biotechniques
@animatedbiologywitharpan14:12129198
qPCR details \| quantitative real time PCR \| RT PCR \| Biotechniques

Quantitative real-time PCR (qPCR) is a molecular biology technique used to detect and quantify specific RNA molecules in real-time during amplification. The method relies on SYBR Green dye, which fluoresces only when bound to double-stranded DNA, allowing the machine to monitor DNA accumulation cycle-by-cycle. The cycle threshold (CT) value indicates the amplification point where fluorescence crosses a detection threshold, with lower CT values signifying higher initial template abundance. Data a

@animatedbiologywitharpan · 14:12
  • Why this video is valuable: A masterful explanation of real-time PCR physics, showing how fluorescent dyes (SYBR Green) and sequence-specific fluorogenic probes (TaqMan) allow physical quantification of amplicon accumulation cycle-by-cycle.
mRNA Purification with GLOBIN RNA DEPLETION: Remove Blood Contamination Before cDNA
mRNA Purification with GLOBIN RNA DEPLETION: Remove Blood Contamination Before cDNA
@adwoabiotech00:51169
mRNA Purification with GLOBIN RNA DEPLETION: Remove Blood Contamination Before cDNA

For DNase I digestion, combine 20μL of RNase H-treated RNA with 5μL DNase I reaction buffer and 2.5μL DNase I enzyme, topping up to 50μL with nuclease-free water. Mix thoroughly by pipetting up and down at least 10 times, then briefly centrifuge. Incubate in thermocycler at 37°C for 30 minutes (lid can be on at 40°C). Briefly spin down after incubation and proceed immediately to RNA purification.

@adwoabiotech · 00:51
  • Why this video is valuable: This brief practical video demonstrates the exact execution of a DNase I digestion reaction protocol (mixing target sample, DNase I enzyme, reaction buffer, and water, followed by incubation). This is the key step used in AAV sample prep to digest non-packaged plasmid DNA before lysing capsids to release the viral genome.
How to generate qPCR Standard Curve & Calculate qPCR assay efficiency in google sheets
How to generate qPCR Standard Curve & Calculate qPCR assay efficiency in google sheets
@BioResource07:3610675
How to generate qPCR Standard Curve & Calculate qPCR assay efficiency in google sheets

This video tutorial demonstrates how to generate a quantitative PCR (qPCR) standard curve and calculate PCR assay efficiency using Google Sheets. The process involves plotting threshold cycle (Ct) values against known template concentrations to create a linear regression curve, from which PCR efficiency can be calculated using the formula E = 10^(-1/slope) - 1. The instructor guides viewers through importing experimental data, creating scatter plots, adding trendlines, and performing mathematica

@BioResource · 07:36
  • Why this video is valuable: Teaches you the mathematics of absolute quantification. You will learn how to plot a standard curve using plasmid DNA dilutions of a known copy number, find the slope, calculate PCR efficiency, and convert AAV sample cycle threshold (Ct) values into a physical genome titer (vg/mL).

Gap Coverage & Self-Directed Learning

⚠️ Practical Gap Acknowledgment: After DNase I digestion (which destroys external, unencapsidated plasmid DNA), the sample must be heated or treated with Proteinase K to destroy the viral protein capsid and release the target therapeutic DNA for qPCR amplification. This capsid-rupturing step is crucial.

To fill this gap, independently search YouTube for: "AAV DNase digestion protocol before qPCR titering" to study the dual-enzymatic prep workflow (DNase I treatment followed by Proteinase K digestion).

Knowledge Checkpoint

  • Explain why treating raw harvested AAV vectors with DNase I prior to capsid lysis is necessary to avoid overestimating the physical titer.
  • Define the "Cycle Threshold" (Ct) and explain its inverse relationship to the starting copy number of your DNA template.
  • Convert a plasmid concentration in ng/μL to physical copy numbers using the molecular weight of the plasmid.

Course Map

Key People Index

  • Dr. Julie Wells: Educator whose practical assay methodologies help clarify cellular dilutions and viral plating parameters.
  • Dr. Tim Miles: Expert on AAV column chromatography, separation engineering, and full/empty capsid analytics.
  • Christine Le Bec (Genethon): Pioneer in downstream validation, specializing in physical analytical methods designed to characterize empty vs. full AAV particles.

Final Self-Assessment

Complete this comprehensive self-assessment checklist before proceeding to wet-lab manufacturing trials:

  • AAV Biology: Can you draw a wild-type AAV genome structure and explain how it differs from a recombinant AAV transfer plasmid?
  • ITR Functions: Do you understand why standard AAV transfer plasmids must keep the inverted terminal repeats (ITRs) intact while removing all other replication and viral capsid open reading frames?
  • Suspension Parameters: Can you list the optimum range of cell density and viability required for suspension HEK293 cells at the point of transfection?
  • Transfection Plasmids: Can you name the three components of a triple-transfection protocol and describe the specific biochemical utility of each?
  • Carrier Chemistry: Can you explain how cationic polymers (e.g., PEI) neutralize and compact negatively charged DNA to overcome the cellular lipid bilayer barrier?
  • Harvest Lysis: Can you explain why physical freeze-thaw cycles or chemical detergent lysis is required to harvest vector particles (specifically for serotypes with low cell secretion, like AAV2)?
  • Ultracentrifugation Physics: Can you define buoyant density and explain how a discontinuous Iodixanol gradient separates full capsids, empty capsids, and host-cell protein contaminants?
  • DNase I Digestion Prep: Can you outline why treating an AAV harvest with DNase I is necessary prior to qPCR titering, and what happens to the resulting signal if you omit this step?
  • TaqMan Chemistry: Can you describe how the 5'-to-3' exonuclease activity of Taq polymerase is utilized in probe-based qPCR assays to yield sequence-specific fluorescent signals?
  • Titer Calculation: Can you successfully build a linear regression model (CqC_q vs. log[DNA Copy Number]) from standard curve data and use it to calculate the exact genomic titer of an unknown AAV vector preparation in units of vg/mLvg/mL?
Explore Further

Related Biotechnology Roadmaps

View All→
biotechnology

Building Gut-on-a-Chip: PDMS, Cells & TEER

01Foundations of Microfluidics and Gut Anatomy
02Cleanroom Fabrication & PDMS Soft Lithography
03Epithelial Cell Culture and On-Chip Seeding
+ 2 more learning modules
26h5 modules
Explore Roadmap
biotechnology

Optimizing CFPS: E. coli Extract & Yield

01Fundamentals of Molecular Biology and Translation
02Introduction to Cell-Free Protein Synthesis (CFPS)
03Preparing E. coli Crude Lysate (The Extract)
+ 2 more learning modules
19h5 modules
Explore Roadmap
biotechnology

Haematococcus PBR: Design, Stress & Astaxanthin

01Biology and Life Cycle of Haematococcus pluvialis
02Bench-Scale Photobioreactor (PBR) Design and Engineering
03Culture Media Formulation and Inoculation
+ 2 more learning modules
15h5 modules
Explore Roadmap
biotechnology

Phage Cocktails: Isolation, Safety & Stability

01Foundations of Bacteriophages and Antibiotic Resistance
02Environmental Isolation and Purification of Phages
03Host-Range Profiling and Cocktail Design
+ 2 more learning modules
24h5 modules
Explore Roadmap